KWON, D. H. .; KIM, G.-Y. .; CHA, H.-J. .; KIM, S.; KIM, H.-S. .; HWANG, H.-J. .; CHOI, Y. H. Nargenicin A1 attenuates lipopolysaccharide-induced inflammatory and oxidative response by blocking the NF-κB signaling pathway. EXCLI Journal, [S. l.], v. 20, p. 968-982, 2021. DOI: 10.17179/excli2021-3506. Disponível em: https://www.excli.de/index.php/excli/article/view/3506. Acesso em: 4 dec. 2021.